This inventor holds 1 USPTO granted patent. Top assignee: Ucb Societe Anonyme. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Innovations of Jean-Pierre Durieux
Introduction
Jean-Pierre Durieux is a notable inventor based in Braine-le-Chateau, Belgium. He has made significant contributions to the field of biochemistry, particularly in the determination of beta-lactam antibiotics. His innovative approach has led to the development of a unique enzymatic process that enhances the accuracy of antibiotic concentration measurements in biological liquids.
Latest Patents
Jean-Pierre Durieux holds a patent for an "Enzymatic process for the determination of beta-lactam antibiotics." This patent outlines a method that involves incubating a biological liquid with a specific enzyme, which reacts with the beta-lactam antibiotic to form an inactive enzyme-antibiotic complex. The process includes several steps, such as separating the enzyme from the liquid, hydrolyzing a substrate solution, and determining the amount of D-alanine formed to ascertain the concentration of the antibiotic.
Career Highlights
Durieux is associated with UCB Société Anonyme, a prominent company in the pharmaceutical sector. His work has been instrumental in advancing methodologies for antibiotic determination, which is crucial for both clinical and research applications. His innovative contributions have positioned him as a key figure in his field.
Collaborations
Throughout his career, Jean-Pierre Durieux has collaborated with esteemed colleagues, including Albert Loffet and Jacques Degelaen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in biochemistry.
Conclusion
Jean-Pierre Durieux's contributions to the field of biochemistry, particularly through his patented enzymatic process, demonstrate his commitment to innovation and excellence. His work continues to impact the determination of antibiotics, showcasing the importance of research and collaboration in advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
